GlassScriptPhysician profile
William Michael Robertson
NPI 1114055944
$1,720.68
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $457 · 2021: $142 · 2022: $18.08 · 2023: $67.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $448.57 | 2019-2020 | |
| Allergan, INC. | $229.78 | 2019-2020 | |
| Abbvie INC. | $175.63 | 2019-2023 | Ubrelvy |
| Amgen INC. | $68.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $65.27 | 2019-2022 | |
| Pfizer INC. | $63.81 | 2019-2023 | |
| Sanofi Pasteur INC. | $58.33 | 2019-2020 | |
| Lilly USA, LLC | $50.02 | 2019-2021 | |
| Antares Pharma, INC. | $50.01 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Janssen Pharmaceuticals, INC | $48.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.53 | 2019-2020 | |
| Glaxosmithkline, LLC. | $41.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.56 | 2019-2020 | |
| Novo Nordisk INC | $37.96 | 2019-2020 | |
| Ibsa Pharma INC. | $36.92 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.68 | 2021 | |
| Eisai INC. | $24.98 | 2021 | |
| Amarin Pharma, INC. | $24.07 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.87 | 2020 | |
| Daiichi Sankyo INC. | $19.29 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.80 | 2019 | |
| Shire North American Group INC | $18.10 | 2019 | |
| Neos Therapeutics, LP | $17.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.50 | 2020 | |
| Bausch Health US, LLC | $15.75 | 2020 | |
| Boston Scientific Corporation | $13.75 | 2023 | |
| Hologic Sales and Service, LLC | $13.30 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.